Press release
-
Business Wire22 hours ago
Shareholder Notice: Robbins LLP Informs Investors of the ARS Pharmaceuticals Inc. Class Action
SAN DIEGO–(BUSINESS WIRE)–$SPRY #Health—Robbins LLP informs shareholders that a securities class action has been filed on behalf of all investors…
Read More » -
Business Wire22 hours ago
I Squared Capital Launches Industrial Logistics and Cold Storage Platform in Indonesia with the Acquisition of Cella from NWP Property & CRE
Acquisition of 5 operational modern logistic and cold storage assets across Greater Jakarta and Surabaya Marks I Squared’s entry into…
Read More » -
Business Wire22 hours ago
River City Bank Announces Pricing of Initial Public Offering
SACRAMENTO, Calif.–(BUSINESS WIRE)–$RCBC #rivercitybank–River City Bank (the “Bank”) today announced the pricing of its initial public offering (IPO) of 2,700,000…
Read More » -
Business Wire22 hours ago
Stockholder Alert: Robbins LLP Informs Investors of the Gildan Activewear Inc. Class Action
SAN DIEGO–(BUSINESS WIRE)–$GIL #Clothing—Robbins LLP informs investors that a securities class action has been filed on behalf of former HanesBrands…
Read More » -
Business Wire22 hours ago
Toshiba Starts Shipping Engineering Samples of TXZ+™ Family Entry‑Class M4V Group, Standard Microcontrollers with Arm® Cortex®‑M4 Core for System Control Applications
―Enhanced security and data management functions support secure system design for IoT equipment and other applications― KAWASAKI, Japan–(BUSINESS WIRE)–Toshiba Electronic…
Read More » -
Business Wire22 hours ago
Nidec Announces a Request by a Shareholder to File an Action
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) announced that it has received today a written request…
Read More » -
Galibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy
Dual designations support development of a potential first disease-modifying therapy for an ultra-rare neurometabolic disorder BOSTON, Aug. 5, 2026 /PRNewswire/…
Read More » -
AI-empowered Pipeline-in-a-drug Option: Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging
As a dual-purpose, potential first-in-class, “pipeline-in-a-drug” candidate, ISM9077 provides an innovative solution for ocular diseases, inflammatory disorders, and the fundamental…
Read More » -
Infor Appoints Yuka Kanemitsu as President and Representative Director of Infor Japan to Accelerate Industry Cloud Growth and AI-Driven Business Transformation
Experienced technology executive to lead Infor’s next phase of growth in Japan, helping customers modernize operations through industry-specific cloud solutions,…
Read More » -
Menu-Order AI Names Dr. Leigh-Anne Dale as Founding Medical Advisor
Physician specializing in Transplant Nephrology, will support educational initiatives for GLP-1 users, physicians and clinicians. BOSTON, Aug. 5, 2026 /PRNewswire/…
Read More »